Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.
Related Collections
Right arrowRelated Article
J Am Soc Nephrol 15:306-315, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

The SOD Mimetic Tempol Ameliorates Glomerular Injury and Reduces Mitogen-Activated Protein Kinase Activity in Dahl Salt-Sensitive Rats

Akira Nishiyama*, Masanori Yoshizumi||, Hirofumi Hitomi*, Shoji Kagami, Shuji Kondo, Akira Miyatake{dagger}, Megumu Fukunaga{ddagger}, Toshiaki Tamaki||, Hideyasu Kiyomoto§, Masakazu Kohno§, Takatomi Shokoji*, Shoji Kimura* and Youichi Abe*

*Department of Pharmacology, {dagger}the Research Equipment Center, {ddagger}Integrated Medicine, and §Second Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan; and Department of ||Pharmacology and Pediatrics, The University of Tokushima School of Medicine, Tokushima, Japan

Correspondence to Dr. Akira Nishiyama, Department of Pharmacology, Kagawa Medical University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. Phone: +81-87-898-5111 (ext. 2502); Fax: +81-87-891-2126; E-mail: akira{at}kms.ac.jp

ABSTRACT. It was shown recently that renal injury in Dahl salt-sensitive (DS) hypertensive rats is accompanied by mitogen-activated protein kinase (MAPK) activation. The present study was conducted to elucidate the contribution of reactive oxygen species to MAPK activities and renal injury in DS rats. DS rats were maintained on high salt (H; 8.0% NaCl; n = 7) or low salt (L; 0.3% NaCl; n = 6) diets; H + a superoxide dismutase mimetic, tempol (3 mmol/L in drinking water; n = 8); or H + hydralazine (0.5 mmol/L in drinking water; n = 8) for 4 wk. Mean BP (MBP) in DS/H and DS/L rats was 185 ± 7 and 113 ± 3 mmHg, respectively. DS/H rats showed a higher ratio of urinary protein excretion and creatinine (UproteinV/UcrV; 20.3 ± 1.1) and a higher cortical collagen content (22 ± 1 µg/mg) than in DS/L rats (2.4 ± 0.1 and 13 ± 1 µg/mg, respectively). The expression of p22-phox and Nox-1, essential components of NAD(P)H oxidase, in renal cortical tissue was approximately threefold higher in DS/H rats than in DS/L rats. Increased activities of renal cortical MAPK, including extracellular signal-regulated kinases (ERK) 1/ERK2 and c-Jun NH2-terminal kinases (JNK) were also observed in DS/H rats by 7.0 ± 0.7- and 4.3 ± 0.2-fold, respectively. Tempol treatment significantly decreased MBP (128 ± 3 mmHg), UproteinV/UcrV (4.8 ± 0.4), and cortical collagen content (14 ± 1 µg/mg) and normalized ERK1/ERK2 and JNK activities in DS/H rats. Histologically, tempol markedly ameliorated progressive sclerotic and proliferative glomerular changes in DS/H rats. Hydralazine-treated DS/H rats showed similar MBP (127 ± 5 mmHg) to tempol-treated DS/H rats. Hydralazine also decreased UproteinV/UcrV (16.2 ± 1.5) and cortical collagen content (19 ± 1 µg/mg) in DS/H rats. However, these values were significantly higher than those of tempol-treated rats. Furthermore, although hydralazine significantly reduced JNK activity (-56 ± 3%), ERK1/ERK2 activities were unaffected. These data suggest that reactive oxygen species, generated by NAD(P)H oxidase, contribute to the progression of renal injury through ERK1/ERK2 activation in DS/H hypertensive rats.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2004 15: A26-A29. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M.-S. Zhou, I. H. Schuman, E. A. Jaimes, and L. Raij
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-{beta}, and fibronectin with concomitant increase in nitric oxide bioavailability
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F53 - F59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande
Signaling pathways modulated by fish oil in salt-sensitive hypertension
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1323 - F1335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. A. Jaimes, M.-S. Zhou, D. D. Pearse, L. Puzis, and L. Raij
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F385 - F392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nagase, H. Matsui, S. Shibata, T. Gotoda, and T. Fujita
Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress
Hypertension, November 1, 2007; 50(5): 877 - 883.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Chao, H.-J. Li, Y.-Y. Yao, B. Shen, L. Gao, G. Bledsoe, and L. Chao
Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity
Hypertension, March 1, 2007; 49(3): 490 - 497.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nagase, S. Shibata, S. Yoshida, T. Nagase, T. Gotoda, and T. Fujita
Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker
Hypertension, June 1, 2006; 47(6): 1084 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Kondo, M. Shimizu, M. Urushihara, K. Tsuchiya, M. Yoshizumi, T. Tamaki, A. Nishiyama, H. Kawachi, F. Shimizu, M. T. Quinn, et al.
Addition of the Antioxidant Probucol to Angiotensin II Type I Receptor Antagonist Arrests Progressive Mesangioproliferative Glomerulonephritis in the Rat
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 783 - 794.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Nagai, K. Miyata, G.-P. Sun, M. Rahman, S. Kimura, A. Miyatake, H. Kiyomoto, M. Kohno, Y. Abe, M. Yoshizumi, et al.
Aldosterone Stimulates Collagen Gene Expression and Synthesis Via Activation of ERK1/2 in Rat Renal Fibroblasts
Hypertension, October 1, 2005; 46(4): 1039 - 1045.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. E. Callera, A. C. I. Montezano, A. Yogi, R. C. Tostes, Y. He, E. L. Schiffrin, and R. M. Touyz
c-Src-Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats
Hypertension, October 1, 2005; 46(4): 1032 - 1038.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP